reduce insulin dose when starting glp-1 receptor agonist glp-1_analogs [TUSOM Is GLP-1 the Same as

Clinical guidelines from DiabetesInControl.com offer valuable insight into proper dosing schedules and patient education tactics

doi: 10.1056/NEJMoa2108269 16 DaviesMJD'AlessioDAFradkinJKernanWNMathieuCMingroneGet al

Yapici-Esper, H., Appadurai, V., Eren, C

A true breakthrough: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity Science , a popular journal published by the American Association for the Advancement of Science (AAAS), has announced that ongoing research into the benefits of GLP-1 agonists such as semaglutide is its 2023 Breakthrough of the Year

Obesity 32(1):5058 Colbourne JR et al (2023) The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery